In this episode, we dive into the world of obesity treatment with Dr. Alexandra Sowa, author of The Ozempic Revolution and a trailblazer in the field of obesity medicine. We explore the revolutionary impact of GLP-1 medications like Ozempic and Wegovy, which are transforming the approach to obesity—a condition affecting nearly half of Americans.
What You'll Learn:
- The science behind GLP-1 medications and how they work to combat obesity.
- Eligibility criteria for these medications and how to access them.
- Addressing common misconceptions and misinformation surrounding GLP-1s.
- Practical strategies for managing side effects and optimizing treatment outcomes.
- The importance of holistic approaches in treating obesity, beyond medication.
About our Guest: Dr. Alexandra Sowa, an expert in internal medicine and obesity medicine, clinical instructor at NYU School of Medicine, and a prominent voice in public discussions on obesity.
Topics Covered:
- The Role of GLP-1 Medications: Understanding their mechanism and who benefits the most.
- Navigating Access and Insurance: Tips on prescription accessibility and insurance coverage.
- Combating Misinformation: Debunking myths and clarifying what users can really expect.
- Lifestyle Integration: How to incorporate these medications into a holistic health regimen.
- Emotional and Psychological Considerations: Handling the mental challenges associated with dramatic weight loss.
- Future of Obesity Treatment: Insights into upcoming advancements and what the next decade could hold.